Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): Mechanisms of contractile depression by nitric oxide

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 2, 1998, Pages 303-315

  Joe, Edwin K ^a   Schussheim, Adam E ^a   Longrois, Dan ^a,c   Mäki, Tiina ^a,d   Kelly, Ralph A ^a   Smith, Thomas W ^a   Balligand, Jean Luc ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^c UNIVERSITÉ DE LORRAINE   (France)

^d Meilahti Hospital   (Finland)

Author keywords

Cardiac myocytes; Cyclic AMP; Cyclic GMP; Cytokines; Isoproterenol; Nitric oxide synthase

Indexed keywords

CYCLIC AMP; CYCLIC GMP; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHODIESTERASE INHIBITOR;

ADRENERGIC STIMULATION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032006524     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0593     Document Type: Article

References (57)

1. ANKER SD, CHUA TP, PONIKOWSKI P, HARRINGTON D, SWAN JW, KOX WJ, POOLE-WILSON PA, COATS AJS, 1997. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96: 526-534.
2. BALLIGAND J-L, UNGUREANU D, KELLY RA, KOBZIK L, PIMENTAL D, MICHEL T, SMITH TW, 1993a. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 91: 2314-2319.
3. BALLIGAND J-L, KELLY RA, MARSDEN PA, SMITH TW, MICHEL T, 1993b. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci USA 90: 347-351.
4. BALLIGAND J-L, UNGUREANU-LONGROIS D, SIMMONS WW, PIMENTAL D, MALINSKI TA, KAPTURCZAK M, TAHA Z, LOWENSTEIN CJ, DAVIDOFF AJ, KELLY RA, SMITH TW, MICHEL T, 1994. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes: characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem 269: 27580-27588.
5. BALLIGAND J-L, KOBZIK L, HAN X, KAYE DM, BELHASSEN L, O'HARA DS, KELLY RA, SMITH TW, MICHEL T, 1995. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 270: 14582-14586.
6. BEAVO JA, 1995. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Phys Rev 75: 725-748.
7. DE BELDER AJ, RADOMSKI MW, WHY HJF, MONCADA S, 1993. Nitric oxide synthase activities in human myocardium. Lancet 341: 84-85.
8. BERGER HJ, PRASAD SK, DAVIDOFF AJ, PIMENTAL D, ELLINGSEN O, MARSH JD, SMITH TW, KELLY RA, 1994. Continual electric field stimulation preserves contractile function of adult ventricular myocytes in primary culture. Am J Physiol 266: H341-H349.
9. BODE DC, KANTER JR, BRUNTON LL, 1991. Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue. Circ Res 68: 1070-1079.
10. BRADY AJ, POOLE-WILSON PA, HARDING SE, WARREN JB, 1992. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 263: H1963-H1966.
11. CAMPBELL DL, STAMLER JS, STRAUSS DC, 1996. Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol 108: 277-293.
12. CHUNG MK, GULICK TS, ROTONDO RE, SCHREINER GF, LANGE LG, 1990. Mechanism of cytokine inhibition of β-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. Circ Res 67: 753-763.
13. CLAYCOMB WC, PALAZZO MC, 1980. Culture of the terminally differentiated adult cardiac muscle cells: a light and scanning electron microscope study. Dev Biol 80: 466-482.
14. COOPER DMF, MONS N, KARPEN JW, 1995. Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 374: 421-424.
15. DUKTA DP, ELBORN JS, DELAMERE F, SHALE DJ, MORRIS GK, 1993. Tumor necrosis factor-α in severe congestive cardiac failure. Br Heart J 70: 141-143.
16. ENGLAND PJ, 1976. Studies on the phosphorylation of the inhibitory subunit of troponin during modification of contraction in perfused rat heart. Biochem J 160: 295-304.
17. FABIATO A, FABIATO F. 1978. Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiac and skeletal muscles. J Physiol (Lond) 276: 233-255.
18. FINKEL MS, ODDIS CV, JACOB TD, WATKINS SC, HATTLER BG, SIMMONS RL, 1992. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-389.
19. GROSS WL, BAK MI, INGWALL JS, ARSTALL MA, BALLIGAND JL, SMITH TW, KELLY RA, 1996. Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve. Proc Natl Acad Sci USA 93: 5604-5609.
20. GULICK T, CHUNG MK, PIEPER SJ, LANGE LG, SCHREINER GF, 1989. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc Natl Acad Sci USA 86: 6753-6757.
21. HABIB FM, SPRINGALL DR, DAVIES GJ, OAKLEY CM, YACOUB MH, POLAK JM, 1996. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 347: 1151-1155.
22. HAN X, SHIMONI Y, GILES WR, 1995. A cellular mechanism for nitric oxide-mediated cholinergic control of mammalian heart rate. J Gen Physiol 106: 45-65.
23. HAN X, KOBZIK L, BALLIGAND J-L, KELLY RA, SMITH TW, 1996. Nitric oxide synthase (NOS3)-mediated cholinergic modulation of Ca current in adult rabbit atrioventricular nodal cells. Circ Res 78: 998-1008.
24. HARE JM, LOH E, CREAGER MA, COLUCCI WS, 1995a. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 92: 2198-2203.
25. HARE JM, KEANEY JF JR, BALLIGAND J-L, LOSCALZO J, SMITH TW, COLUCCI WS, 1995b. Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs. J Clin Invest 95: 794-802.
26. HAYWOOD GA, TSAO PS, VON DER LEYEN HE, MANN MJ, KEELING PJ, TRINDALE PT, LEWIS NP, BYME CD, RICKENBACHER PR, BISHOPRIC NH, COOKE JP, MCKENNA WJ, FOWLER MB, 1996. Expression of inducible nitric oxide synthase in human heart failure. Circulation 93: 1087-1094.
27. HOFMANN PA, LANGE JH, 1994. Effects of phosphorylation of troponin I and C protein on isometric tension and velocity of unloaded shortening in skinned single cardiac myocytes from rats. Circ Res 74: 718-726.
28. KATZ SD, RAO R, BERMAN JW, SCHWARZ M, DEMOPOULOS L, BIJOU R, LEJEMTEL TH, 1994. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure: relation to nitric oxide-dependent vasodilation in the forearm circulation. Circulation 90: 12-16.
29. KOJDA G, KOTTENBERG K, NIX P, SCHLUTER KD, PIPER HM, NOACK E, 1996. Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ Res 78: 91-101.
30. LEVINE B, KALMAN J, MAYER L, FILLIT HM, PACKER M, 1990. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323: 236-241.
31. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ, 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
32. MÄKI T, KONTULA K, MYLLYNEN P, HARKONEN M, 1987. β-adrenergic receptors of human lymphocytes in physically active and immobilized subjects: characterization by a polyethylene glycol precipitation assay. Scand J Clin Lab Invest 47: 261-267.
33. MATSUMORI A, YAMADA T, SUZUKI H, MATOBA Y, SASAYAMA S, 1994. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 72: 561-566.
34. MCMURRAY J, ABDULLAH I, DARGIE HJ, SHAPIRO D, 1991. Increased concentrations of tumor necrosis factor in 'cachectic' patients with severe chronic heart failure. Br Heart J 66: 356-358.
35. 2+ current is regulated by cGMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci USA 88: 1197-1201.
36. + current: Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 268: 26286.
37. MERY PF, HOVE-MADSEN L, CHESNAIS J-M, HARTZELL HC, FISCHMEISTER R, 1996. Nitric oxide synthase does not participate in negative inotropic effect of acetylcholine in frog heart. Am J Physiol 270: H1178-H1188.
38. MOHAN P, BRUTSAERT DL, PAULUS W, SYS SU, 1996. Myocardial contractile response to nitric oxide and cyclic GMP. Circulation 93: 1223-1229.
39. MOPE L, MCCLELLAN GB, WINEGRAD S, 1980. Calcium sensitivity of the contractile system and phosphorylation of troponin in hyperpermeable cardiac cells. J Gen Physiol 75: 271-282.
40. MUBAGWA K, SHIRAYAMA, T, MOREAU M, PAPPANO AJ, 1993. Effects of PDE inhibitors and carbachol on the L-type Ca current in guinea pig ventricular myocytes. Am J Physiol 265: H1353-H1363.
41. ORAL H, DORN GW, MANN DL, 1997. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Biol Chem 272: 4836-4842.
42. REUTER H, 1983. Calcium channel modulation by neurotransmitters, enzymes and drugs. Nature (London) 301: 569-574.
43. SCATCHARD G, 1949. The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51: 660-672.
44. SEAMON KB, PADGETT W, DALY JW, 1981. Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci USA 78: 3363-3367.
45. SEAMON KB, DALY JW, 1986. Forskolin: its biological and chemical properties. Adv Cyclic Nucleotide Prot Phosphorylation Res 20: 1-150.
46. SHAH AM, SPURGEON HA, SOLLOTT SJ, TALO A, LAKATTA EG, 1994. 8-Bromo-cyclic GMP reduces the myofilament response to calcium in intact cardiac myocytes. Circ Res 74: 970-978.
47. SOLARO RJ, MOIR AJ, PERRY SV, 1976. Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart. Nature 262: 615-617.
48. 2+ current in rat ventricular myocytes. Circ Res 77: 803-812.
49. TORRES J, DARLEAY-USMAR V, WILSON MT, 1995. Inhibition of cytochrome c oxidase turnover by nitric oxide: Mechanisms and implications for control of respiration. Biochem J 312: 169-173.
50. UNGUREANU-LONGROIS D, BALLIGAND JL, KELLY RA, SMITH TW, 1995a. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol 27: 155-167.
51. UNGUREANU-LONGROIS D, BALLIGAND J-L, SIMMONS WW, OKADA I, KOBZIK L, LOWENSTEIN CJ, KUNKEL SL, MICHEL T, KELLY RA, SMITH TW, 1995a. Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to β-adrenergic agonists. Circ Res 77: 494-502.
52. WAHLER GM, DOLLINGER SJ, 1995. Nitric oxide donor Sin-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am J Physiol 268 (Cell Physiol 37) C45-C54.
53. WEISHAAR RE, KOBYLARZ-SINGER DC, KAPLAN HR, 1987. Subclasses of cAMP phosphodiesterase in cardiac muscle. J Mol Cell Cardiol 19: 1025-1036.
54. WINLAW DS, SMITHE GA, KEOGH AM, SCHYVENS CG, SPRATT PM, MACDONALD PS, 1994. Increased nitric oxide production in heart failure. Lancet 344: 373-374.
55. YAMAMOTO S, TSUTSUI H, TAGAWA H, SAITO K, TAKAHASHI M, TADA H, YAMAMOTO M, KATOH M, EGASHIRA K, TAKESHITA A, 1997. Role of myocyte nitric oxide in β-adrenergic hyporesponsiveness in heart failure. Circulation 95: 111-114.
56. ZAKHAROV SI, PIERAMICI S, KUMAR GK, PRABHAKAR NR, HARVEY RD, 1996. Nitric oxide synthase activity in guinea-pig ventricular myocytes is not involved in muscarinic inhibition of cAMP-regulated ion channels. Circ Res 78: 925-935.
57. ZHANG R, ZHAO J, MANDVENO A, POTTER JD, 1995. Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation. Circ Res 76: 1928-1035.